Skip to main content

Mª Jesús Cruz Carmona

Institutions of which they are part

Head of group
Pneumology
Vall Hebron Institut de Recerca

Mª Jesús Cruz Carmona

Institutions of which they are part

Head of group
Pneumology
Vall Hebron Institut de Recerca

Projects

Contrato Rio Hortega

IP: Mª Jesús Cruz Carmona
Collaborators: David Espejo Castellanos, Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 65000
Reference: CM23/00174
Duration: 18/03/2024 - 17/03/2026

Grup de Recerca en Pneumologia

IP: Jaume Ferrer Sancho
Collaborators: Sergi Martí Beltran, Marta Vicenta Arjona Perís, Christian Eduardo Romero Mesones, Maria Angeles Jiménez Fuentes, Mª Jose Jurado Luque, Marc Miravitlles Fernández, Ana Villar Gomez, Antonio Álvarez Fernandez, Victor Monforte Torres, Odile Romero Santo-Tomas, Miriam Barrecheguren Fernández, David Clofent Alarcón, Carles Bravo Masgoret, Mario Culebras Amigo, Fco. Javier Muñoz Gall, Gabriel Sampol Rubio, Maria Antonia Ramon Belmonte, Mercedes Pallero Castillo, Mª Jesús Cruz Carmona, Cristina Berastegui Garcia, Almudena Felipe Montiel, Eva Maria Revilla Lopez, Gerard Orriols Torras, Julia Sampol Sirvent, Meritxell Boada Perez, David Espejo Castellanos, Manuel López Meseguer, David Soler Segovia, Susana Gómez Olles, Berta Saez Gimenez, Iñigo Ojanguren Arranz, Eva Polverino, Letizia Traversi
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 00788
Duration: 01/01/2022 - 30/06/2025

MicroRNA expression profiles in asthmatic patients with different disease phenotypes exposed to pollutants.

IP: Mª Jesús Cruz Carmona
Collaborators: Maria Florencia Pilia, Judit Álvarez González
Funding agency: Instituto de Salud Carlos III
Funding: 89900
Reference: FI22/00262
Duration: 01/01/2023 - 31/12/2027

Air pollution and microRNA expression in asthmatic patients: Effects on inflammatory and oxidative stress lung markers.

IP: Mª Jesús Cruz Carmona
Collaborators: David Soler Segovia
Funding agency: Instituto de Salud Carlos III
Funding: 141570
Reference: PI21/01346
Duration: 01/01/2022 - 31/12/2024

Related news

Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

Related professionals

Marta Vicenta Arjona Perís

Marta Vicenta Arjona Perís

Predoctoral researcher
Pneumology
Read more
Anna Casteras  Román

Anna Casteras Román

Research technician
Diabetes and Metabolism
Read more
Pedro Pablo Jordán Marchite

Pedro Pablo Jordán Marchite

Predoctoral researcher
Cardiovascular Diseases
Read more
Mónica Azucena Villarreal Salazar

Mónica Azucena Villarreal Salazar

Predoctoral researcher
Neuromuscular and Mitochondrial Pathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.